Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
39.61
0.41 (1.05%)
At close: Oct 03, 2025, 3:59 PM
39.61
0.00%
After-hours: Oct 03, 2025, 04:39 PM EDT
1.05% (1D)
| Bid | 28.91 |
| Market Cap | 3.05B |
| Revenue (ttm) | 10.02M |
| Net Income (ttm) | -278.23M |
| EPS (ttm) | -3.75 |
| PE Ratio (ttm) | -10.56 |
| Forward PE | -8.52 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 50.26 |
| Volume | 507,797 |
| Avg. Volume (20D) | 842,698 |
| Open | 39.41 |
| Previous Close | 39.20 |
| Day's Range | 39.16 - 40.14 |
| 52-Week Range | 26.74 - 46.00 |
| Beta | 1.14 |
| Ex-Dividend Date | n/a |
About XENE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XENE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XENE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-17.43%
Xenon Pharmaceuticals shares are trading lower. Th...
Unlock content with
Pro Subscription
4 months ago
+2.37%
Xenon Pharmaceuticals shares are trading lower. The company reported Q1 financial results.
1 month ago · seekingalpha.com
Xenon Pharmaceuticals Inc. (XENE) Q2 2025 Earnings Call TranscriptXenon Pharmaceuticals Inc. (NASDAQ:XENE ) Q2 2025 Earnings Conference Call August 11, 2025 4:30 PM ET Company Participants Chad Fugere - Vice President, Investor Relations Christopher John Kenney - Ch...